Johnson And Johnson trades as part of the drug manufacturers industry and is part of the healthcare sector. The company CEO is Alex Gorsky. Johnson and Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.
Previous Intraday Trading Performance:
The JNJ stock showed a previous change of 0.27% with an open at 131.95 and a close of 132.40. It reached an intraday high of 132.46 and a low of 131.54.
The stock has a market cap of $355.1b with 2.7b shares outstanding, of which the float is 2.7b shares. Trading volume reached 4,425,933 shares compared to its average volume of 7,921,098 shares. Based on the current average volume and close price, the trading liquidity is good.
Historical Trading Performance:
Over the last five trading days, Johnson And Johnson shares returned -0.36% and in the past 30 trading days it returned 3.92%. Over three months, it changed -3.13%. In one year it has changed -5.35% and within that year its 52-week high was 148.99 and its 52-week low was 118.62. JNJ stock is 11.62% above its 52 Week Low.
Our calculations show a 200 day moving average of 131.16 and a 50 day moving average of 133.75. Currently JNJ stock is trading 0.95% above its 200 day moving average and may be a good opportunity to buy.
The last annual fiscal EPS for the company was reported at 8.18 that ended on 31st of December 2018, which according to the previous close, that is a PE of 23.60. Based on 7 analyst estimates, the consensus EPS for the next quarter is 1.95. The TTM EPS is 8.18, which comes to a TTM PE of 16.19. Historically, the PE high was 310.40 and the PE low was 14.30. If the stock reached its PE low, that would represent a price of 116.94, which is a decrease of -11.67%.
The following are the last four quarter reported earnings per share:
The dividend per share is currently 3.60, which is a dividend yield of 2.72%. Also, the payout ratio is 44.01%, therefore the dividend is safe according to our calculations.
Base on our calculations, the intrinsic value per share is 177.34, which means it is possibly undervalued and has a margin of safety of 25.34%
Indicators to Watch:
Based on the latest filings, there is 98.50% of institutional ownership. Short-interest is 14,012,467, which is 0.52% of shares outstanding. The short-interest ratio or days-to-cover ratio is 1.20. This stock has some short interest, but it may be normal and no cause for concern if long the position.
The current calculated beta is 0.68
PR Newswire: Invesco Closed-End Funds Declare Dividends
Based on last reported financials, the company’s return on assets is 9.82%, profit margin is 18.73%, price-to-sales is 4.34 and price-to-book is 5.49.
All scores are out of six:
1 :Valuation Score
4 :Past Performance Score
3 :Financial Strength Score
3 :Future Growth Score
5 :Dividend Score
3 :Overall Score